These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3491151

  • 61. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 62. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.
    Warren HS, Skipsey LJ.
    Immunology; 1991 Sep; 74(1):78-85. PubMed ID: 1834549
    [Abstract] [Full Text] [Related]

  • 63. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
    Kalland T.
    J Immunol; 1986 Oct 01; 137(7):2268-71. PubMed ID: 2876040
    [Abstract] [Full Text] [Related]

  • 64. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
    Yoshino I, Yano T, Miyamoto M, Sugimachi K, Kimura G, Nomoto K.
    Lymphokine Cytokine Res; 1993 Aug 01; 12(4):191-6. PubMed ID: 8218591
    [Abstract] [Full Text] [Related]

  • 65. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis.
    Del Prete GF, Vercelli D, Tiri A, Maggi E, Mariotti S, Pinchera A, Ricci M, Romagnani S.
    Clin Exp Immunol; 1986 Jul 01; 65(1):140-7. PubMed ID: 3024884
    [Abstract] [Full Text] [Related]

  • 66. Natural killer cells induce activated murine B cells to secrete Ig.
    Snapper CM, Yamaguchi H, Moorman MA, Sneed R, Smoot D, Mond JJ.
    J Immunol; 1993 Nov 15; 151(10):5251-60. PubMed ID: 8228222
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.
    Mittler RS, Greenfield RS, Schacter BZ, Richard NF, Hoffmann MK.
    J Immunol; 1987 May 15; 138(10):3159-66. PubMed ID: 2952710
    [Abstract] [Full Text] [Related]

  • 75. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
    Gong JH, Maki G, Klingemann HG.
    Leukemia; 1994 Apr 15; 8(4):652-8. PubMed ID: 8152260
    [Abstract] [Full Text] [Related]

  • 76. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase.
    Beckner SK, Farrar WL.
    J Immunol; 1988 Jan 01; 140(1):208-14. PubMed ID: 2447168
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.